Journal
RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY
Volume 3, Issue 3, Pages 211-213Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/187221309789257360
Keywords
Dehydroepiandrosterone; asthma; allergic diseases; urticaria
Categories
Ask authors/readers for more resources
Dehydroepiandrosterone (DHEA) and its sulfate derivative (DHEA - S) are weak androgens produced in the adrenals and serve as primary precursors in biosynthesis of both, androgens and estrogens. These hormones are proposed to perform immunoenhancing activities and may play a crucial role in regulating cytokine production by Th1/Th2 cells; however, their role in immune-mediated diseases is controversial. The primary physiological role of DHEA-(S) and its mechanism is unclear. This review is a brief summary of relevant scientific basis as well as clinical research on the role of dehydroepiandrosterone in immune haemostasis and inflammatory diseases, including asthma, atopic diseases, chronic urticaria, pointing also to the significance of dehydroepiandrosterone therapy and the related US patents (1999-2005).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available